The first lies within the nature of mutant p53 found in cancer cells, where endogenous mutant p53 exerts a dominant negative inhibition of WT p53, reducing or eliminating the tumor-suppressing activities of WT p53 (Figure 3). Here, TP53 is linked to neoplasm.